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Abstract
Objectives: Breast cancer is known as one of the deadliest
forms of cancer, and it is increasing globally. There are a
variety of proven and controversial risk factors for this
malignancy. Herein, we aimed to undertake a systematic
review and meta-analysis focus on the epidemiology of
breast cancer risk factors in Iran.
Methods: We performed a systematic search via PubMed,
Scopus, Web of Science, and Persian databases for iden-
tifying studies published on breast cancer risk factors up to
March 2019. Meta-analyses were done for risk factors re-
ported in more than one study. We calculated odds ratios
(ORs) with corresponding 95% confidence intervals (CIs)
using a fixed/random-effects models.
Results: Thirty-nine studies entered into themeta-analysis.
Pooling of ORs showed a significant harmful effect for risk
factors including family history (OR: 1.80, 95%CI 1.47–2.12),
hormonal replacement therapy (HRT) (OR: 5.48, 95%CI
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0.84–1.74), passive smokers (OR: 1.68, 95%CI 1.34–2.03),
full-term pregnancy at age 30 (OR: 3.41, 95%CI 1.19–5.63),
abortion (OR: 1.84, 95%CI 1.35–2.33), sweets consumption
(OR: 1.71, 95%CI 1.32–2.11) and genotypeArg/Arg (crudeOR:
1.59, 95%CI 1.07–2.10), whereas a significant protective
effect for late menarche (OR: 0.58, 95%CI 0.32–0.83), nul-
liparity (OR: 0.68, 95%CI 0.39–0.96), 13–24 months of
breastfeeding (OR: 0.68, 95%CI 0.46–0.90), daily exercise
(OR: 0.59, 95%CI 0.44–0.73) and vegetable consumption
(crude OR: 0.28, 95%CI 0.10–0.46).
Conclusions: This study suggests that factors such as
family history, HRT, passive smokers, late full-term
pregnancy, abortion, sweets consumption and genotype
Arg/Arg might increase risk of breast cancer development,
whereas late menarche, nulliparity, 13–24 months breast-
feeding, daily exercise and vegetable consumption had an
inverse association with breast cancer development.
Keywords: breast carcinoma; breast tumor; mammary
neoplasm; meta-analysis; population at risk.
Introduction
Breast cancer is one of the most common health concerns
throughout the world [1–4], which includes 30% of female
cancers [5, 6]. It is also known as the second cause of death
in developed countries and the third leading cause of death
in less developed countries [7–9]. Surprisingly, approxi-
mately 502,000 women die due to breast cancer annually
[10]. According to the World Health Organization (WHO)
prediction, up to 2.3 million women will be diagnosed for
breast cancer by 2050 [11, 12].
In Iran, breast cancer has been identified as the most
common cancer and also the fifth main cause of death
among Iranian women [4, 13]. The standardized incidence
rate (ASR) is about 28 per 100,000 people, which has
increased in recent years [14]. There are a variety of proven
and controversial risk factors for breast cancer. The
American Cancer Society has reported that only about a
quarter of breast cancers are due to identified risk factors.
These factors include aging, urban life, social class (upper-
middle class), marital status (single), white race, history of
ovarian cancer, early menarche age, late menopause age,
history of breast cancer, history of fibrocystic breast dis-
ease, family history of breast, uterine and ovarian cancers,
and history of radiation exposure. However, it seems that
numerous factors have not yet been identified [15].
According to the Iran, aging, history of breast cancer,
genetic modification, chest radiation therapy, diethylstil-
bestrol (DES) intervention, using hormonal replacement
therapy (HRT), low levels of vitamin D, exposure to
chemicals in cosmetics, diet, obesity [16], smoking [17],
alcohol, fertility and hormonal factors, contraceptives,
early menarche, late menopause, high age at first birth,
absence of labor history, other malignancies such as
ovarian and endometrial carcinoma, are all the most
commonly reported risk factors for breast cancer [18, 19].
Considering the incidence and prevalence of breast
cancer, the high cost of treatment, risk of involvement in
women who are productive in social and socioeconomic
settings (>35-year-old) and lack of national screening or
early diagnosis, breast cancer is an important subject, the
importance of which is reported widely [20–23].
Despite the importance of the associated risk factors
with this malignancy, there is no nationwide study in this
regard according to our knowledge. Hence, we aimed to
undertake a systematic review and meta-analysis focus on
the epidemiology of breast cancer risk factors in Iran. We
hope our findings could provide a comprehensive report to
be useful for future studies.
Method
Search strategy
WefollowedPreferredReporting Items for SystematicReviews
and Meta-Analyses (PRISMA) guideline for study design,
searchprotocol, screening, and reporting.A systematic search
was performed via international databases of PubMed, Sco-
pus, and Web of Science until 05 March 2019. Moreover, for
finding Persian papers, we used Google Scholar database and
national databases of Scientific Information Database (SID),
Iranmedex, and Magiran. The search strategy included MeSH
terms and free keywords as follows: ((Breast OR Mammary)
AND (Cancer* ORNeoplasm* OR Tumor* ORMalignancy* OR
Carcinoma*) AND (“Risk factor” OR “Risk factors” OR “Pop-
ulation at Risk” OR “Populations at Risk”) AND AND Iran).
Persian equivalent words were used for searching in national
databases. There was no limitation about the date of publi-
cations in our search.
Criteria study selection
Two group members (A.SH and K.HD) selected the papers
independently and discussed to solve the disagreements.
Studies met the following criteria included in the meta-
analysis: (1) comparative studieswith a control group such as
case-control and cross-sectional; and (2) studies reported the
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risk factors of female breast cancer patients in Iran. Studies
were excluded if they were: (1) conference abstracts, com-
ments, letters, animal studies, reviews, case reports, and in
vitro studies; (2) duplicate publications; and (3) included
insufficient data for calculating desired parameters.
Data extraction & quality assessment
Two researchers (Z.SH and K.HD) have independently
evaluated the quality of studies and extracted data from
included papers. The supervisor (R.AN) resolved any dis-
agreements in this part. Data extraction checklist included
the name of the first author, publication year, a region of
study, number of patients, mean age, quantitative infor-
mation of risk factors, clinicopathological features, and
available correlations.
The Newcastle-Ottawa Scale (NOS) checklist was used
to value the selected papers in relation to various aspects of
the methodology and study process.
Data analysis
Statistical analysis was performed using STATA v.11 soft-
ware. To assess the heterogeneities, we used the I-square
(I2) test. According to the studies heterogeneity, we pooled
results using a fixed-effects or random-effects model as




Our initial search through databases resulted in 562 papers.
After excluding duplicated papers, remained papers
screened using title and abstract. Finally, after eligibility
assessment of 84 full texts, 41 studies entered into quali-
tative synthesis, and finally, 39 studies entered into the
meta-analysis. PRISMA flow diagram for the study selec-
tion process is presented in Figure 1.
Study characteristics
Out of 39 included studies, 35 studies were case-control,
and four of them were cross-sectional studies. The studies’
sample size ranged from 93 to 25,592, including 54,347
participants. Nine studies were conducted in Tehran
province, six in Fars, four in Mazandaran, four in Isfahan,
three in East Azerbaijan, two in Guilan, two in Kerman-
shah, one inWest Azerbaijan, one in Golestan, one in Yazd,
one in Hormozgan, one in Khuzestan, and one in Razavi
Khorasan. Moreover, one study was a joint study between
Mazandaran and Guilan, and one study between Tehran
and East Azerbaijan. Characteristics of studies entered into
meta-analysis presented in Table 1.
Quality assessment
According to quality assessment using the NOS checklist,
39 studies earned the minimum eligibility score and
entered into the meta-analysis. It is remarkable that the
NOS modified checklist was used for cross-sectional
studies [63]. Only one paper was excluded due to a low
score. Summary of risk of bias presented in Figure 2. for
details, see Supplementary material 2.
Risk factors for breast cancer
According to included studies, over 20 risk factors were
reported for breast cancer. The factors reported in only one
study, which seems to be rare are as follows: High-fat foods
and dairy (e. g. milk, yogurt, and cheese) [62], Fast foods
[62], Genital surgery (surgeries related to uterus and ovary
such as hysterectomy or oophorectomy) [30, 40], Hope-
lessness [26], Hair coloring [55], Human papillomavirus
infection [37], Epstein–Barr virus infection [64], Ovarian
cancer [41], Supplements of selenium, calcium, Vit B12 and
Vit D [58].Figure 1: PRISMA flowchart for study selection process.
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Figure 2: Risk of bias summary. A: Case-control studies; B: Cross-sectional studies.
Table : Summarized pooled ORs of considered risk factors.
















Age  . . . (., .)  . . . (., .)




 . . . (−., .)
Less than  years  . . . (., .)
Between  and
 years
 . . . (., .)  . . . (., .)
Less than  years  . . . (., .)
Less than  years  . . . (., .)
More than  years  . . . (., .)  . . . (., .)
Body mass index status
Unknown categorization  . . . (., .)  . . . (., .)
Between  and .  . . . (., .)  . . . (., .)
More than   . . . (., .)  . . . (., .)
Relationship status
Single  . . . (., .)
Married  . . . (−., .)
Divorced  . . . (., .)
Education level
Basic education  . . . (., .)  . . . (., .)
Academic education  . . . (., .)  . . . (., .)
Smoking status
Active smoker  . . . (., .)  . . . (., .)
Passive smoker  . . . (., .)  . . . (., .)
Daily exercise  . . . (., .)  . . . (., .)
Menopausal status  . . . (., .)  . . . (., .)
Hormone replacement
therapy
 . . . (., .)  . . . (., .)
Oral contraceptive  . . . (., .)  . . . (., .)
Age at first full-term
pregnancy
– years  . . . (., .)  . . . (., .)
– years  . . . (., .)  . . . (., .)
 years  . . . (., .)  . . . (., .)
Birth giving status
Nulliparity  . . . (., .)  . . . (., .)
Abortion  . . . (., .)  . . . (., .)
Previous benign breast  . . . (., .)
X-ray exposure  . . . (., .)  . . . (., .)
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The factors reported in more than one study are as follows:
Age, Family history, Menarche age, Body mass index
(BMI), Relationship status, Education Level, Smoking sta-
tus, Daily exercise, Menopausal status, HRT, Oral contra-
ceptive, birth-giving status, Abortion status, Benign Breast
Conditions, X-ray exposure, Breastfeeding duration, Di-
etary status (including sweets, egg, fish, and vegetables),
Genotype status and Residency status.
Only clear well-known risk factors reported in two or
more studies entered into the meta-analysis.
Individual-related risk factors (Table 2)
Age
Age was considered as a risk factor in four papers. The
meta-analysis showed no significant difference be-
tween groups for breast cancer occurrence regarding
age (OR: 1.04, 95%CI 0.97–1.11). A significant hetero-
geneity was observed (I2=80.6%, p=0.023) (Supple-
mentary material 1).
Family history
Eighteen studies reported on a family history of breast
cancer. The meta-analysis between two groups showed
that the odds of breast cancer development was 1.80 times
higher in subject with a family history of breast cancer (OR:
1.80, 95%CI 1.47–2.12). A modest heterogeneity was
observed (I2=24.3%, p=0.205) (Supplementary material 1).
Menarche age
This factor was studied in Nine articles. The meta-analysis
showed a significant protective effect for menarche age
more than 15 (OR: 0.58, 95%CI 0.32–0.83). Moderate het-
erogeneity was observed in this regard (I2=35.3%, p=0.201)
(Supplementary material 1).
Body mass index
BMI was investigated in nine studies. The meta-analysis
indicated no significant differences between groups for
BMI status (OR: 1.04, 95%CI 0.99–1.09), BMI 25–29.9 (OR:
1.07, 95%CI 0.82–1.32) andBMImore than 30 (OR: 1.21, 95%
CI 0.90–1.52) (Supplementary material 1).
Relationship status
Thirteen papers were studied relationship status. The
meta-analysis found that there were no significant
differences between groups regarding single status (crude
OR: 0.98, 95%CI 0.74–1.23), married status (crude OR:
0.64, 95%CI −0.25 to 1.54) and divorced status (crude OR:
1.15, 95%CI 0.87–1.43) (Supplementary material 1).
Table : (continued)

















Breastfeeding  . . . (., .)  . . . (., .)
– months  . . . (., .)
– months  . . . (., .)  . . . (., .)
– months  . . . (−., .)  . . . (−., .)
More than  months  . . . (−., .)
Dietary status
Egg  . . . (−., .)
Fish  . . . (., .)
Sweets  . . . (., .)  . . . (., .)
Vegetables  . . . (., .)
Genotype status
Arg/Arg  . . . (., .)
Arg/Pro  . . . (., .)
Genital surgery  . . . (., .)
Residency status
Rural  . . . (., .)
Shamshirian et al.: Breast cancer risk factors in Iran 9
Education level
This factor was studied in 15 papers. According to meta-
analysis, no significant differences were found for both
basic education level (OR: 1.18, 95%CI 0.70–1.66) and
academic education level (OR: 0.67, 95%CI 0.24–1.10)
(Supplementary material 1).
Smoking status
Six papers studied this factor. Themeta-analysis showed that
the odds of breast cancer occurrence was 1.68 times higher in
thepassive smokers (OR: 1.68, 95%CI 1.34–2.03).However, no
significant relationships were observed for active smokers
(OR: 1.70, 95%CI 0.66–2.74) (Supplementary material 1).
Daily exercise
Three studies were included with this factor. The daily
exercise showed a protective effect on the occurrence of
breast cancer (OR: 0.59, 95%CI 0.44–0.73). No heterogeneity
wasobserved (I2=0.0%,p=0.678) (Supplementarymaterial 1).
Menopausal status
Thirteen studies have investigated this factor. No significant
relationships were observed between groups in this regard
(OR: 1.29, 95%CI 0.84–1.74). High heterogeneity was
observed (I2=73.9%, p<0.0001) (Supplementary material 1).
Hormone replacement therapy
HRT was studied in five papers. The meta-analysis indi-
cated that the odds of breast cancer occurrence was 5.48
time higher in the group with HRT history (OR: 5.48, 95%CI
0.84–1.74). No significant heterogeneity was observed
(I2=0.0%, p=0.509) (Supplementary material 1).
Oral contraceptive
A history of OCP intake was discussed in 15 papers. The
meta-analysis showed no significant differences be-
tween groups in this regard (OR: 1.17, 95%CI 0.77–1.57).
High heterogeneity was observed (I2=86.9%, p<0.0001)
(Supplementary material 1).
Birth giving status
Age at first full-term pregnancy was considered in six
studies. Meta-analysis showed a significant difference for
age 20 to 24 (OR: 1.92, 95%CI 1.14–2.71) and age 30 (OR:
3.41, 95%CI 1.19–5.63) in this regard, but no substantial
relationships were found for age 25 to 29 (OR: 1.55, 95%CI
0.82–2.29) (Supplementary material 1).
Six studies investigated the relation of nulliparity and
chance of breast cancer development. The meta-analysis
results indicated that this condition has an inverse relation
with the occurrence of breast cancer (OR: 0.68, 95%CI
0.39–0.96) (Supplementary material 1).
Moreover, five papers studied the history of abortion. A
significant difference in odds was observed in the meta-
analysis of two groups. Subjects with a history of abortion
have a higher chance of breast cancer development (OR:
1.84, 95%CI 1.35–2.33). No significant heterogeneity was
observed (I2=0.0%, p=0.393) (Supplementary material 1).
Benign breast conditions
Data from five studieswere combined for themeta-analysis
of benign breast history as a risk factor to develop breast
cancer. No significant difference was observed in this re-
gard (crude OR: 1.24, 95%CI 0.82–1.67) (Supplementary
material 1).
X-ray exposure
This factor was studied in four papers. No significant dif-
ferences were observed regarding the history of X-rays
exposure between cases and controls (OR: 1.02, 95%CI
0.19–1.86). A significant heterogeneity was observed
(I2=83.6%, p=0.002) (Supplementary material 1).
Breastfeeding duration
This factor was investigated in seven studies. The meta-
analysis revealed that 13–24 months of breastfeeding has
an inverse association with breast cancer occurrence (OR:
0.68, 95%CI 0.46–0.90). No significant heterogeneity was
observed (I2=0.0%, p=0.624) (Supplementary material 1).
Dietary status
This factorwas studied for egg, fish, sweets, and vegetables.
The meta-analysis revealed that egg (crude OR: 0.92, 95%
CI −0.64 to 2.47) and fish (crude OR: 1.47, 95%CI 0.68–2.25)
do not affect the chance of breast cancer occurrence
significantly (Supplementary material 1). However, findings
showed that the odds of developing breast cancer were
higher in individuals with high sweets consumption (OR:
1.71, 95%CI 1.32–2.11) (Supplementary material 1) and lower
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in subjects with regular vegetable consumption (crude OR:
0.28, 95%CI 0.10–0.46) (Supplementary material 1).
Genotype status
Two studies were investigated p53 codon 72 polymorphisms
as a breast cancer risk factor. Although genotype Arg/Pro
(crude OR: 0.69, 95%CI 0.37–1.00) was not related to the
odds of breast cancer development, a significantly higher
chance found for genotype Arg/Arg (crude OR: 1.59, 95%CI
1.07–2.10) in this regard (Supplementary material 1).
Genital surgery
Genital surgery was considered in two studies. No signifi-
cant differenceswere found regarding the history of genital
surgery for breast cancer development (crudeOR: 1.37, 95%
CI 0.87–1.86) (Supplementary material 1).
Residency status
The place of living was investigated in two studies. The
meta-analysis delivered no significant difference between
two groupswith rural and urban residency status for breast
cancer occurrence (crude OR: 1.37, 95%CI 0.87–1.86)
(Supplementary material 1).
Discussion
We undertook this systematic review and meta-analysis to
identify the risk factors contributing to the occurrence of
female breast cancer in Iran. Out of 39 included papers,
more than 60 factors were studied as breast cancer risk
factors, of which only 27 factors entered the meta-analysis.
Out of all risk factors, factors including family history, HRT,
passive smokers, late full-term pregnancy, abortion,
sweets consumption, and genotype Arg/Arg indicated to
be significantly associated with a higher chance of breast
cancer development. In contrast, factors of late menarche,
nulliparity, 13–24 months of breastfeeding, daily exercise,
and vegetable consumption, were demonstrated to be
protective. The other remaining risk factors were not
associated with the development of breast cancer.
A family history of breast cancer was one of the asso-
ciated risk factors for breast cancer development in our
study. In one of the first meta-analysis on “Family history
and the risk of breast cancer”, Pharoah et al. [65] pooled
estimate of relative risk (RR) indicated that the probability
of breast cancer occurrence is higher in those individuals
with a family history of this malignancy (RR: 1.9, 95%CI,
1.7–2.0). They also found that this probability is higher in
first-degree relatives, especially mother and sister (RR: 3.6,
95%CI 2.5–5.0). There are many other studies that reported
the association of family history with the risk of breast
cancer [66–68].
High levels of estrogen can increase the chance of
breast cancer development through genotoxic stress in-
duction and breast tissue mutations [69, 70]. Therefore,
receiving external estrogen through HRT may increase the
risk of breast cancer development. In this regard,HRTusers
showed the highest chance of developing breast cancer in
our meta-analysis (OR: 5.48, 95%CI 0.84–1.74), inconsis-
tent with several studies [71–73]. In contrast, the study of
Bae et al. reported no significant association in this regard
among Korean Women [74].
In our meta-analysis, although passive smokers were
at higher risk of breast cancer development, no significant
association was found for active smokers in this case. Our
findingswere in the same linewith the systematic review of
Chen et al. [75] among Chinese females, which implied that
passive smokers were at higher risk of breast cancer
development (OR: 1.62, 95%CI 1.39–1.85), but not active
smokers (OR: 1.04, 95%CI 0.89–1.20). Moreover, some
other studies reported a significant association between
passive smoking and the risk of breast cancer [76–78].
Regarding the age at first full-term pregnancy, our re-
sults were in the same line with previous studies, which
indicated the increased risk of breast cancer in individuals
with late first full-term pregnancy (at age 30 or older) [79,
80]. For nulliparity conditions, our study showed an in-
verse association with breast cancer development, which
was in contrast with several previous reports [81, 82].
Numerous investigators have studied the association of
induced abortion and the risk of breast cancer throughout the
world. One of the oldest studies titled “Induced abortion as a
cancer risk factor” discussed the induced abortion as a breast
cancer risk factor [83]. Similarly, some meta-analysis also
reported the same conclusions [84, 85]. In this regard, our
meta-analysis found that induced abortion was significantly
associated with the risk of breast cancer in Iranian women.
Besides, the study of Deng et al. demonstrated that induced
abortionmightbe related to the riskof breast cancer inparous
women (OR: 1.11, 95%CI 1.02–1.20, p=0.01), but not in
nulliparous women (OR:1.02, 95%CI 0.86–1.21, p=0.85). In
contrast, several studies arrived at contradictory conclusions
[86, 87].
The meta-analysis findings showed a significant as-
sociation between sweet foods consumption and the risk of
breast cancer. Although we did not find a specific sys-
tematic review in this regard, several epidemiological
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studies in different regions reported the association of
sweet foods consumption and risk of breast cancer [88–91].
For example, Tavani et al. performed a comprehensive
case-control study in Italy and found a direct relationship
between sweet foods consumption and risk of breast can-
cer development [91]. In fact, excessive sweets intake with
a high glycemic index may cause insulin resistance as well
as insulin-related growth factors as promoters of breast
carcinogenesis. Moreover, ovarian steroid secretion,
including estrogens and androgens, might be stimulated
by insulin. Altogether, these processes end up at an
increased risk of breast cancer [92, 93].
Previous studies have investigated the relationships of
p53 codon 72 polymorphisms and the risk of breast cancer
development in different regions [94]. In this investigation,
we found that the genotype Arg/Arg is associated with the
development of breast cancer, whichwas inconsistent with
the study of Al-Qasem et al. among Saudi women, and in
contrast with meta-analysis carried out by Ma et al. and
Hou et al. studies [95, 96].
Menarche age does not precisely match with the breast
cancer onset. However, they are significantly correlated [97].
This meta-analysis demonstrated an inverse association
between late menarche age and risk of breast cancer (OR:
0.58, 95%CI 0.32–0.83). Our findings were in the same di-
rection with two other meta-analyses carried out by Li et al.
[98] and Collaborative Group onHormonal Factors in Breast
Cancer [99].
We found that longer breastfeeding duration (13–24
months) plays a protective rule against breast cancer
development, inconsistent with numerous meta-analysis
in various populations [100–103]. In this regard, according
to one of themost comprehensive studies on “Breast cancer
and breastfeeding” including 47 epidemiological studies in
30 countries, breast cancer development would be reduced
by 42%, especially in developing countries becausewomen
in these countries usually have a long duration of breast-
feeding throughout their lives [104]. In contrast, short
breastfeeding duration, which is usual among women in
developed countries with small family size, would
contribute to a higher risk of breast cancer development in
such countries [104].
The updated report “Food, Nutrition, Physical Activity,
and the Prevention of Cancer: A Global Perspective” in 2007,
recommended physical activity as a protective factor
against cancers, especially post-menopausal breast cancer
[105]. It was also recommended by the “American Cancer
Society Guidelines on nutrition and physical activity for
cancer prevention” [106]. Our findings also support this
hypothesis as a preventive factor for breast cancer devel-
opment. In fact, physical activities affect the risk of cancer
development through mechanisms such as metabolic,
reproductive effects, hormonal, and immunity enhance-
ment, etc. [107]. The comprehensive study of Moore et al.
[108] titled “Association of Leisure-Time Physical Activity
with Risk of 26 Types of Cancer in 1.44 Million Adults” re-
ported the significant association for high and low physical
activity and lower risk of breast cancer (hazard ratio (HR):
0.9, 95%CI 0.87–0.93).
The association between vegetable intake and risk of
breast cancerwas always controversial. Our results suggest
a protective effect of vegetable consumption on the risk of
breast cancer. In the same direction, meta-analyses carried
out by Liu et al., Woo et al., and Aune et al. indicated a
significant association between various types of vegetables
and dietary fiber consumption and risk of breast cancer
development [109–111]. In contrast, several systematic re-
views and meta-analysis showed no significant relation-
ships in this regard [112, 113], and some others were
controversial regarding the types of vegetables and their
combination intake with fruits as well as breast cancer
types [114, 115].
According to the retrospective nature of the included
studies, it is recommended to design some longitudinal
cohort investigations in order to examine the funda-
mental role of these risk factors in breast cancer
development.
Conclusion
Based on this systematic review andmeta-analysis, factors
including a family history of breast cancer, HRT, passive
smokers, abortion, sweets consumption, and genotype
Arg/Arg, play a significant role in the development of
breast cancer. In contrast, late menarche, nulliparity, long
breastfeeding duration, regular physical activity, and
consumption of vegetables showed a significant inverse
association with breast cancer occurrence.
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